| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-14 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |